Currently Enrolling Clinical Trials
Patients, Advocates and Medical Professionals:
For more information:
http://www.clinicaltrials.gov
Jennerex is currently recruiting for the following studies:
Colorectal Cancer
A Phase 1b Dose Escalation Study of JX-594 Administered Every Two Weeks Intravenous Infusion in Patients With Metastatic, Refractory Colorectal Carcinoma
Clinicaltrials.gov identifier: NCT01380600
Liver Cancer
A Phase 2b randomized Single-Blinded Trial of JX-594 Plus Best Supportive Care Versus Placebo Plus Best supportive Care in Patients With Advanced Hepatocellular Carcinoma Who Have Failed Sorafenib treatment
Clinicaltrials.gov identifier: NCT01387555
A Phase 2 Open-Label Pilot Safety Study of JX-594 Administered by IV Infusion Followed by Intertumoral Injection Prior to Standard Soranfenib Treatment in Patients With Unresectable Primary Hepatocellular Carcinoma
Clinicaltrials.gov identifier: NCT01171651
Pediatric
A Phase 1 Open-Label, Dose Escalation Study of JX-594 Administered by Intertumoral Injection in Patients With Unresectable Refractory Solid Tumors
Clinicaltrials.gov identifier: NCT01169584
